SCHEMBL22308926

SCHEMBL22308926

CC1(C)c2ccccc2N(c2nc(-c3ccccc3)nc(-c3cccc(-c4cccc(-c5cc(-c6ccccc6)nc(-c6ccccc6)n5)c4)c3)n2)c2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.44
▸ KMT2A Q03164 8/20 0.44
▸ HPGD P15428 7/20 0.44
▸ MAPT P10636 7/20 0.44
▸ ALDH1A1 P00352 6/20 0.44
▸ KDM4E B2RXH2 5/20 0.44
▸ LMNA P02545 2/20 0.44
▸ GLA P06280 1/20 0.44
▸ NTSR1 P30989 1/20 0.39
▸ ADORA2A P29274 2/20 0.37
▸ ADORA1 P30542 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ MAPK1 P28482 3/20 0.34
▸ MAOB P27338 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ MAOA P21397 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ CASP7 P55210 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22113750 0.99 MEN1 (0.43) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL22308743 0.90 MEN1 (0.45) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL22308742 0.90 MEN1 (0.45) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL22309919 0.90 MEN1 (0.45) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL22309913 0.88 HPGD (0.40) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL15490803 0.87 L3MBTL1 (0.44) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL13231668 0.86 MEN1 (0.40) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL13833079 0.86 MEN1 (0.41) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL13832934 0.85 MEN1 (0.42) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL22969836 0.85 MEN1 (0.40) MEN1KMT2AHPGDMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 — — US disclosed
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 — — US disclosed
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME VDAC1, OR10J3, PIEZO1 MEN1 2484/4885KMT2A 2549/4885HPGD 3640/4885
US-11917910-B2 Organic compound and organic electroluminescent device using the same VDAC1, OR10J3, PIEZO1 MEN1 2484/4885KMT2A 2549/4885HPGD 3640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback